The National Heart, Lung, and Blood Institute (NHLBI) has 3 targeted funding opportunities with deadlines in February. It’s also not too early to start preparing for the April 5 Omnibus solicitation deadline. Check your registrations (SAM must be renewed annually!) and reach out to discuss your project.
For questions about the NHLBI SBIR/STTR programs, contact Small Business Coordinator Jennifer Shieh, PhD at This email address is being protected from spambots. You need JavaScript enabled to view it.
Human Cellular Models for Predicting Individual Responses to CFTR-Directed Therapeutics— Due February 9
For the development and validation of novel in vitro human cell-based tools for predicting the responses of individual patients to cystic fibrosis transmembrane conductance regulator (CFTR)-directed therapeutics for cystic fibrosis lung disease.
SBIR: RFA-HL-15-027 STTR: RFA-HL-15-026
For questions about these funding opportunities, contact:
Robert Smith, PhD, This email address is being protected from spambots. You need JavaScript enabled to view it.
Program Director, Division of Lung Diseases
Development of a Microfluidic Platform for Blood Testing in Neonatal & Pediatric Patients— Due February 10 (Phase II only)
For the development of microfluidic devices to analyze blood for factors related to the thrombotic, transfusion, and/or hemostatic status of pediatric/neonatal patients.
SBIR—Phase II only: RFA-HL-14-026
This application must be based on an awarded SBIR or STTR-funded Phase I project.
For questions about this funding opportunity, contact:
Ronald Warren, PhD, This email address is being protected from spambots. You need JavaScript enabled to view it.
Program Director, Division of Blood Diseases and Resources
Stem Cell-Derived Blood Products for Therapeutic Use: Technology Improvement— Due February 20
For tools and technologies that enable further advances in the manufacturing process to produce safe and functional blood and platelet products at reduced costs.
SBIR: RFA-HL-15-030 STTR: RFA-HL-15-029
Slides from the January 8 webinar are available—please send a request to This email address is being protected from spambots. You need JavaScript enabled to view it..
For questions about these funding opportunities, contact:
Shimian Zou, PhD, This email address is being protected from spambots. You need JavaScript enabled to view it.
Program Director, Division of Blood Diseases and Resources
John Thomas, PhD, This email address is being protected from spambots. You need JavaScript enabled to view it.
Program Director, Division of Blood Diseases and Resources